logo

Myriad Genetics Inc. (MYGN)



Trade MYGN now with
  Date
  Headline
7/31/2018 4:07:48 PM Myriad Genetics Completed Acquisition Of Counsyl
7/18/2018 7:06:22 AM Myriad Announces Coverage Decision By Kroger Prescription Plans For Vectra DA
6/28/2018 7:09:29 AM Myriad Genetics: BRACAnalysis CDx Identifies Patients Who Respond To Lynparza In SOLO-1 Study
6/21/2018 7:06:46 AM Myriad Genetics Receives Positive Medical Policy Decision For Prolaris Prostate Cancer Test
6/18/2018 7:08:09 AM Myriad Genetics Says FDA Accepted SPMA Application For BRACAnalysis CDx
6/6/2018 7:06:24 AM Crescendo Bioscience To Present Data On Use Of The Vectra DA Test
6/1/2018 7:09:37 AM Myriad Genetics Presents Second Pivotal Validation Study For RiskScore Test At 2018 ASCO Annual Meeting
5/8/2018 6:43:47 AM Myriad Genetics Inc. (MYGN) Has Raised Its 2018 EPS Estimate To 1.19 - 1.21 From 1.11 - 1.16
5/8/2018 6:43:15 AM Myriad Genetics Inc. (MYGN) Has Raised Its 2018 Revenue Estimate To $771 - $773 Mln From $760 - $770 Mln
5/8/2018 6:31:10 AM Myriad Genetics Q3 Adjusted EPS $0.31 Vs $0.27 Last Year
4/2/2018 7:13:16 AM Myriad Gets Pre-Market Approval For BRACAnalysis Diagnostic System In Japan